The bill
A resolution supporting the goals and ideals of World Malaria Day.
SRES. 173, 119th Congress β read as touching Pharmaceuticals.
Sponsored by
Sen. Wicker, Roger F. [R-MS]
ID: W000437
Follow the money
The bill
SRES. 173, 119th Congress β read as touching Pharmaceuticals.
The sponsor
Every bill has someone who introduced it. That name is where the paper trail starts.
The money
25 itemised contributions to this sponsor, pulled from FEC filings.
Track this bill's progress through the legislative process
Latest Action
Invalid Date
π Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
(sigh) Oh joy, another meaningless resolution from our esteemed leaders in Congress. Let's dissect this farce.
**Main Purpose & Objectives:** The main purpose of SRES 173 is to pretend that the Senate cares about malaria, a disease that still kills hundreds of thousands of people worldwide every year. The objectives are to (1) support the goals and ideals of World Malaria Day, (2) declare it's in the national interest to fight malaria, and (3) pat themselves on the back for past progress.
**Key Provisions & Changes to Existing Law:** There are no actual provisions or changes to existing law. This is a non-binding resolution, which means it's nothing more than a feel-good statement with no teeth. It's like writing a strongly worded letter to the editor and expecting it to change the world.
**Affected Parties & Stakeholders:** The affected parties include (1) malaria victims worldwide, who will continue to suffer and die regardless of this resolution; (2) pharmaceutical companies, which might see increased funding for research and development of new malaria treatments; and (3) politicians, who get to pretend they care about global health issues.
**Potential Impact & Implications:** The potential impact is zero. This resolution won't save a single life or prevent one case of malaria. It's a PR stunt designed to make Congress look like it cares about global health. The implications are that our leaders will continue to prioritize empty rhetoric over actual action, and the public will continue to be duped into thinking something meaningful is being done.
Diagnosis: This resolution suffers from a severe case of "Congressional Malaria Fatigue Syndrome" (CMFS), characterized by symptoms such as:
* Empty rhetoric * Lack of concrete action * Prioritization of PR over policy * Failure to address root causes of the problem
Treatment: None. This disease is terminal, and the only cure is a complete overhaul of our dysfunctional political system.
Prognosis: Poor. We can expect more of the same empty resolutions and meaningless gestures from Congress, while malaria continues to ravage communities worldwide.
Sen. Wicker, Roger F. [R-MS]
Congress 119 β’ 2024 Election Cycle
No PAC contributions found
No committee contributions found
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 37 nodes and 25 connections (40 secondary connections hidden)
Total contributions: $682,800
Showing top 21 donors by contribution amount
Which industries are materially affected by specific provisions in this bill. 4 helped.
The bill supports efforts to research and develop more effective and affordable tools for malaria prevention, diagnosis, and treatment (Section 7), which could benefit pharmaceutical companies involved in malaria vaccine development and treatment.
The bill welcomes public-private partnerships to research and develop more effective and affordable tools for malaria prevention, diagnosis, and treatment (Section 7), which could benefit biotechnology research firms working on malaria-related projects.
The bill aims to reduce malaria case incidence and mortality rates, which could lead to lower healthcare costs for insurance providers (Section 5).
The bill's goal of reducing malaria prevalence and deaths could lead to fewer hospitalizations and lower treatment costs for hospitals and health systems (Section 3).
For each industry this bill affects, here's what the sponsor (Sen. Wicker, Roger F. [R-MS])received from donors associated with that industry during the 2022βpresent cycles. Donations are not proof of intent β they are a record of who funds the people writing the law.
An original bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes.
119/s/4784
National Defense Authorization Act for Fiscal Year 2026
119/s/2296
USMMA Athletics Act of 2026
119/s/3266